EW
USDEdwards Lifesciences Corporation Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$83.050
Máximo
$84.830
Mínimo
$82.890
Volumen
2.64M
Fundamentos de la Empresa
Capitalización de Mercado
49.4B
Industria
Dispositivos médicos
País
United States
Estadísticas de Negociación
Volumen Promedio
4.58M
Bolsa
NYQ
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Truist Securities Maintains Hold on Edwards Lifesciences, Raises Price Target to $90
Truist Securities analyst Richard Newitter maintains Edwards Lifesciences with a Hold and raises the price target from $87 to $90.
Barclays Maintains Overweight on Edwards Lifesciences, Raises Price Target to $99
Barclays analyst Matt Miksic maintains Edwards Lifesciences with a Overweight and raises the price target from $95 to $99.
Citigroup Maintains Buy on Edwards Lifesciences, Raises Price Target to $96
Citigroup analyst Joanne Wuensch maintains Edwards Lifesciences with a Buy and raises the price target from $95 to $96.
JP Morgan Maintains Neutral on Edwards Lifesciences, Raises Price Target to $90
JP Morgan analyst Robbie Marcus maintains Edwards Lifesciences with a Neutral and raises the price target from $85 to $90.
Goldman Sachs Maintains Buy on Edwards Lifesciences, Raises Price Target to $104
Goldman Sachs analyst David Roman maintains Edwards Lifesciences with a Buy and raises the price target from $94 to $104.
Piper Sandler Reiterates Overweight on Edwards Lifesciences, Raises Price Target to $95
Piper Sandler analyst Adam Maeder reiterates Edwards Lifesciences with a Overweight and raises the price target from $90 to $95.
RBC Capital Maintains Outperform on Edwards Lifesciences, Raises Price Target to $95
RBC Capital analyst Shagun Singh maintains Edwards Lifesciences with a Outperform and raises the price target from $89 to $95.
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.